Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10930666rdf:typepubmed:Citationlld:pubmed
pubmed-article:10930666lifeskim:mentionsumls-concept:C0014662lld:lifeskim
pubmed-article:10930666lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:10930666lifeskim:mentionsumls-concept:C0019944lld:lifeskim
pubmed-article:10930666lifeskim:mentionsumls-concept:C0024432lld:lifeskim
pubmed-article:10930666lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:10930666lifeskim:mentionsumls-concept:C0036718lld:lifeskim
pubmed-article:10930666lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:10930666pubmed:issue1lld:pubmed
pubmed-article:10930666pubmed:dateCreated2000-9-14lld:pubmed
pubmed-article:10930666pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10930666pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10930666pubmed:abstractTextAn attenuated equine infectious anemia virus (EIAV), named V26, was previously obtained after 50 passages of the Japanese virulent strain V70 in primary macrophage culture. To clarify the differences between both viruses, their full-length sequences were determined. There were higher mutations in S2 (6.15% amino acid difference) and LTR (10.7% nucleotide difference). The presumed initiation codon of the S2 gene was absent from the sequence of V26. There was a large insertion within the long-terminal repeat (LTR) U3 hypervariable region of V26. In addition, there were minor mutations in gag (1.22% amino acid difference), pol (1.05% amino acid difference) and env (1. 65% amino acid difference) regions, but no mutation in tat region. No mutations were observed in the principal neutralizing domain in the gp90. Thus, the mutations in the S2 and LTR might be the major target sites of mutation in EIAV during serial passages in vitro.lld:pubmed
pubmed-article:10930666pubmed:languageenglld:pubmed
pubmed-article:10930666pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10930666pubmed:citationSubsetIMlld:pubmed
pubmed-article:10930666pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10930666pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10930666pubmed:statusMEDLINElld:pubmed
pubmed-article:10930666pubmed:monthJunlld:pubmed
pubmed-article:10930666pubmed:issn0168-1702lld:pubmed
pubmed-article:10930666pubmed:authorpubmed-author:IkutaKKlld:pubmed
pubmed-article:10930666pubmed:authorpubmed-author:KonoYYlld:pubmed
pubmed-article:10930666pubmed:authorpubmed-author:SentsuiHHlld:pubmed
pubmed-article:10930666pubmed:authorpubmed-author:ZhengY HYHlld:pubmed
pubmed-article:10930666pubmed:issnTypePrintlld:pubmed
pubmed-article:10930666pubmed:volume68lld:pubmed
pubmed-article:10930666pubmed:ownerNLMlld:pubmed
pubmed-article:10930666pubmed:authorsCompleteYlld:pubmed
pubmed-article:10930666pubmed:pagination93-8lld:pubmed
pubmed-article:10930666pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:meshHeadingpubmed-meshheading:10930666...lld:pubmed
pubmed-article:10930666pubmed:year2000lld:pubmed
pubmed-article:10930666pubmed:articleTitleMutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages.lld:pubmed
pubmed-article:10930666pubmed:affiliationNational Institute of Animal Health, Tsukuba, Ibaraki, Japan.lld:pubmed
pubmed-article:10930666pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10930666pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10930666lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10930666lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10930666lld:pubmed